standard
assay
use
influenza
serolog
present
certain
practic
issu
interlaboratori
variabl
complex
protocol
necess
handl
certain
viru
strain
high
biolog
contain
facil
attempt
address
avian
human
influenza
ha
pseudotyp
retrovirus
success
employ
antibodi
neutral
assay
studi
gener
equin
influenza
pseudotyp
lentiviru
serolog
screen
achiev
cotransfect
cell
plasmid
express
haemagglutinin
ha
protein
subtyp
equin
influenza
viru
strain
hiv
gagpol
firefli
luciferas
report
gene
harvest
viru
supernat
order
produc
infect
pseudotyp
particl
necessari
addit
cotransfect
plasmid
encod
endoproteas
cleav
ha
high
titr
pseudotyp
viru
pv
use
pv
antibodi
neutral
assay
pvna
success
distinguish
vaccin
nonvaccin
equin
sera
also
screen
singl
radial
haemolysi
srh
assay
correl
result
two
assay
pvna
assay
appear
slightli
sensit
futur
work
extend
test
pvna
larger
number
serum
sampl
assess
sensitivityspecif
interintralaboratori
variabl
defin
protect
titr
influenza
infect
equin
speci
rel
common
signific
econom
impact
primari
clinic
manifest
acut
respiratori
diseas
date
infect
associ
two
subtyp
isol
viru
hors
year
webster
virus
subtyp
continu
caus
outbreak
regularli
across
globe
affect
larg
number
anim
review
dali
et
al
equin
influenza
infect
induc
neutralis
antibodi
surfac
glycoprotein
haemagglutinin
ha
neuraminidas
na
primari
protect
immun
respons
elicit
natur
infect
vaccin
cellmedi
immun
play
role
clear
virusinfect
cell
follow
natur
infect
paillot
et
al
human
influenza
measur
antibodi
ha
particular
import
studi
determin
vaccin
efficaci
ie
perform
experiment
vaccin
challeng
studi
effect
ie
well
vaccin
perform
use
routin
field
haemagglutin
inhibit
hi
test
use
viru
characteris
diagnost
purpos
strainspecif
assay
howev
high
level
interlaboratori
variat
observ
result
protect
antibodi
level
illdefin
rang
titr
mumford
wood
equin
influenza
requir
treat
viru
tween
ether
improv
sensit
assay
john
fulgitini
increas
variabl
assay
hi
test
measur
inhibit
ha
bind
cell
ha
globular
head
reactiv
antibodi
singl
radial
haemolysi
srh
assay
measur
complementmedi
haemolysi
induc
influenza
antibodyantigen
complex
srh
test
standardis
use
refer
sera
dali
et
al
clear
relationship
demonstr
prechalleng
antibodi
level
measur
srh
protect
afford
challeng
studi
mumford
wood
howev
srh
assay
disadvantag
rel
cumbersom
perform
requir
use
sheep
blood
guinea
pig
complement
result
zone
haemolysi
measur
either
use
specialis
equip
hand
use
digit
callip
measur
viru
neutralis
vn
antibodi
equin
influenza
rare
perform
vn
assay
egg
timeconsum
labourintens
lack
cytopath
effect
cell
often
requir
twostep
assay
reduct
viru
replic
measur
detect
viral
protein
elisa
assay
use
equin
influenza
pseudotyp
lentivirus
may
provid
solut
requir
reliabl
reproduc
assay
assess
level
neutralis
antibodi
equin
influenza
vaccin
naturallyinfect
hors
number
avian
human
influenza
viru
subtyp
pseudotyp
use
serolog
assay
temperton
et
al
temperton
wright
corti
et
al
garcia
lai
pseudotyp
viru
core
one
viru
eg
retroviru
outer
envelop
protein
anoth
eg
ha
influenza
viru
core
viru
delet
genom
make
replicationdefici
harbour
report
transgen
eg
luciferas
envelop
glycoprotein
permit
entri
suscept
target
cell
cell
transduct
pseudotyp
viru
pv
genom
becom
integr
cell
genom
express
report
gene
thu
number
transduc
cell
quantifi
subsequ
inhibitori
effect
antibodi
serum
pv
entri
determin
temperton
et
al
temperton
wright
garcia
lai
aim
current
studi
develop
pseudotyp
viru
neutral
assay
pvna
measur
neutralis
antibodi
subtyp
equin
influenza
virus
stock
influenza
viru
european
lineag
strain
dali
et
al
grown
embryon
hen
egg
serum
sampl
surplu
diagnost
requir
obtain
routin
influenzavaccin
donkey
donkey
recent
within
day
vaccin
booster
dose
commerci
avail
inactiv
vaccin
contain
americanlineag
strain
europeanlineag
strain
addit
epitopebear
region
virus
share
amino
acid
ident
determin
use
clustal
softwar
batch
serum
hyperimmunis
experiment
poni
vaccin
number
strain
two
decad
use
posit
control
serum
sampl
two
hors
confirm
srh
kindli
provid
prof
ann
cullinan
irish
equin
centr
sera
store
use
viral
rna
extract
allanto
fluid
use
qiamp
viral
rna
extract
kit
qiagen
full
haemagglutinin
gene
amplifi
titan
one
tube
rtpcr
roch
use
custom
primer
invitrogen
bind
gene
termini
pcr
fragment
digest
bglii
xhoi
restrict
enzym
clone
express
plasmid
use
previous
influenza
ha
pseudotyp
temperton
et
al
plasmid
prepar
purifi
use
kit
qiagen
accord
manufactur
instruct
influenza
pseudotyp
lentiviru
particl
express
firefli
luciferas
report
gene
gener
plasmid
cotransfect
temperton
et
al
figur
approxim
human
embryon
kidney
cell
american
type
cell
cultur
seed
cm
diamet
steril
plastic
dish
nunc
dmem
medium
glutamax
high
glucos
gibco
invitrogen
plu
vv
foetal
bovin
serum
sigma
vv
penicillinstreptomycin
fisher
place
co
vv
humidifi
incub
hr
next
gagpol
construct
zufferey
et
al
firefli
luciferas
construct
pcsflw
wright
et
al
proteas
plasmid
et
al
combin
ad
medium
mixtur
roch
cell
accord
manufactur
instruct
follow
day
medium
replac
exogen
solubl
clostridium
perfringen
na
sigma
ad
facilit
sialic
acid
cleavag
pseudotyp
viru
egress
cell
cultur
supernat
harvest
hr
pass
pore
steril
syring
filter
aliquot
store
viru
supernat
ad
plate
along
target
cell
total
medium
per
well
incub
hr
next
brightglo
luciferas
reagent
promega
ad
incub
min
room
temperatur
luminesc
measur
use
glomax
luminomet
rel
luminesc
unit
rlu
per
ml
autoluminesc
normalis
use
cell
control
determin
pvna
perform
use
standard
protocol
temperton
et
al
briefli
seriallydilut
sera
individu
incub
viru
supernat
rlu
per
well
calcul
titrat
result
hr
permit
antibodi
attach
viru
particl
next
cell
ad
well
incub
hr
luminesc
read
describ
test
sampl
result
normalis
deduct
background
luminesc
produc
cellonli
control
pseudotyp
viru
addit
noserum
control
cell
plu
virus
includ
equival
neutral
ic
antibodi
titr
reciproc
serum
dilut
give
inhibit
pseudotyp
viru
entri
calcul
use
graphpad
prism
comput
softwar
valu
consid
neg
katz
et
al
garcia
lai
averag
valu
two
independ
experi
shown
srh
assay
perform
describ
oie
world
organis
anim
health
terrestri
manual
oie
use
antigen
order
gener
infecti
subtyp
equin
influenza
pseudotyp
viru
eipv
particl
necessari
cotransfect
plasmid
express
endoproteas
transmembran
proteas
serin
famili
member
cleav
ha
detect
viru
produc
absenc
plasmid
eipv
supernat
produc
titr
rluml
eipvcontain
supernat
produc
use
assay
equin
serum
sampl
normal
data
shown
tabl
sampl
vaccin
anim
exhibit
ic
antibodi
titr
posit
control
serum
show
strong
neutral
ic
antibodi
titr
serum
sampl
anim
cutoff
neg
result
antibodi
detect
srh
posit
control
serum
field
sera
srh
antibodi
level
rang
mm
tabl
data
two
assay
compar
use
graphpad
prism
softwar
pearson
analysi
assum
normalgaussian
sampl
distribut
reveal
signific
p
correl
r
valu
result
current
standard
serolog
assay
anim
human
influenza
serolog
eg
assess
vaccin
efficaci
field
epidemiolog
haemagglutin
inhibit
hi
singl
radial
haemolysi
srh
microneutr
mn
although
well
establish
often
labourintens
suffer
consist
problem
use
nativ
pathogen
virus
sometim
requir
test
whether
subtyp
eipv
could
use
detect
neutral
antibodi
equin
inocul
vaccin
contain
subtyp
influenza
virus
comparison
made
establish
serolog
assay
srh
natur
infect
newli
synthesis
influenza
viru
haemagglutinin
protein
cleav
specif
endoproteas
subunit
allow
entri
suscept
cell
review
steinhauer
garten
klenk
mediat
bind
sialic
acid
receptor
involv
membran
fusion
number
proteas
implic
cleavag
process
highlypathogen
avian
influenza
hpai
virus
subtyp
eg
aviet
polybas
cleavag
site
contain
multipl
arginin
lysin
residu
cleav
ubiquit
subtilisinlik
endoproteas
furin
review
steinhauer
influenza
virus
includ
low
pathogen
avian
influenza
virus
season
human
influenza
equin
influenza
virus
monobas
cleavag
site
singl
lysin
arginin
residu
figur
shown
cleavag
site
mediat
specif
type
ii
transmembran
serin
proteas
hat
human
airway
trypsinlik
proteas
found
human
airway
et
al
consequ
includ
plasmid
express
proteas
transfect
procedur
mediat
cleavag
monobas
cleavag
site
equin
pseudotyp
viru
approach
high
titr
eipv
success
gener
pseudotyp
viru
neutral
assay
pvna
detect
neutral
antibodi
sera
vaccin
equin
neg
control
ic
gener
agreement
antibodi
level
measur
pvna
srh
although
two
serum
sampl
antibodi
detect
srh
display
moder
neutral
antibodi
level
measur
pvna
previou
studi
shown
good
correl
influenzaspecif
antibodi
titr
equin
sera
natur
infect
influenza
measur
srh
viru
neutralis
assay
morley
et
al
furthermor
srh
antibodi
level
shown
correl
protect
subsequ
challeng
mumford
wood
though
antibodi
detect
srh
larg
neutral
morley
et
al
differ
srh
neutral
assay
pvna
microneutr
mn
ha
srh
primarili
detect
respons
result
antibodi
interact
head
trimer
though
detect
viral
protein
wherea
neutral
assay
also
care
handl
contain
facil
biosafeti
level
bsl
retroviru
pseudotyp
technolog
use
diagnost
purpos
basic
research
number
pathogen
rna
virus
otherwis
would
handl
laboratori
includ
ebola
viru
woollewi
bate
ito
et
al
hepat
c
bartosch
et
al
hsu
et
al
sar
coronaviru
nie
et
al
temperton
et
al
rabi
lyssavirus
wright
et
al
well
avian
influenza
virus
temperton
et
al
contrast
nativ
virus
pseudotyp
counterpart
handl
facil
proofofprincipl
studi
firstli
aim
produc
hightitr
eipv
research
tool
secondli
tabl
equin
influenza
subtypespecif
antibodi
equin
sera
measur
pseudotyp
viru
neutral
assay
pvna
singl
radial
haemolysi
srh
shade
use
indic
rel
antibodi
level
respons
srh
mm
light
grey
mm
medium
grey
mm
dark
grey
pvna
light
grey
medium
grey
dark
grey
effici
detect
respons
ha
stalk
corti
et
al
may
explain
two
pvna
posit
srh
neg
result
comparison
srh
neutral
use
swine
embryo
kidney
esk
cell
hi
test
use
serum
sampl
hors
receiv
two
dose
vaccin
yamagishi
et
al
found
reason
correl
assay
correl
srh
assay
neutralis
test
r
compar
correl
r
seen
srh
pvna
present
studi
yamagishi
et
al
also
found
srh
assay
less
sensit
hi
neutralis
test
data
similarli
indic
slightli
greater
sensit
neutral
assay
use
pseudotyp
virus
compar
srh
pvna
develop
assess
sensit
specif
assay
also
intend
test
robust
reproduc
assay
evalu
interand
intralaboratori
variabl
final
protect
titr
determin
use
sera
obtain
vaccin
challeng
studi
